Key data
| Regulation | Agreement of 27 October 2026, of the CNMV Board, on delegation of powers |
|---|---|
| BOE Publication | 6 November 2026 |
| Entry into force | 6 November 2026 |
| Affected parties | Listed companies, securities issuers and financial entities supervised by the CNMV |
| Category | Business Regulation |
| Year | 2026 |
| BOE Reference | BOE-A-2026-23339 |
If your company is planning an IPO, a capital increase with prospectus or any primary market operation supervised by the CNMV, this agreement directly affects you. It does not change the rules of the game, but it does change who makes the decisions and with what level of authority.
The Agreement of 27 October 2026 of the CNMV Board reorganizes the internal delegation of supervisory powers, distributing them among four hierarchical levels: Presidency, Vice-Presidency, Executive Committee and Managing Directors. Published in the BOE on 6 November 2026, it entered into force on that same day.
What does this regulation establish?
The agreement distributes the CNMV's supervisory powers in primary markets among the following bodies, with clearly differentiated powers:
| Body | Delegated powers |
|---|---|
| Presidency and Vice-Presidency | Verify admissions to trading; approve and register prospectuses and supplements; manage public offerings for sale (OPV) and subscription (OPS). Exception: first admissions without prior prospectus. |
| Executive Committee | Deny admissions to trading; transfer prospectus approval powers to other EU Member States; authorize information omissions in prospectuses; manage shareholding distribution requirements. |
| Managing Directors | Operational and ordinary management powers within their functional areas. |
The most relevant exception for companies making their stock market debut: first admissions without prior prospectus are excluded from delegation to Presidency and Vice-Presidency, which means this type of case will follow a different decision circuit.
This reorganization does not modify the regulatory framework applicable to issuers and investors (securities market legislation remains the same), but it does precisely determine which specific body will resolve each type of case.
Economic and operational impact
The direct impact of this agreement is not economic in terms of new fees or sanctions, but rather operational and strategic: it affects timelines and the strategy for accessing capital markets.
- Streamlining of ordinary cases: By delegating to Presidency and Vice-Presidency the approval of prospectuses and standard admissions, the burden on the full Board is reduced, which in theory can shorten resolution times in ordinary primary market operations.
- Sensitive decisions centralized: Denials, information omissions and transfer of powers to other Member States remain in the hands of the Executive Committee, the collegiate body with the greatest weight. This adds a layer of deliberation in the most complex or controversial cases.
- Planning of OPV and OPS: Companies preparing a public offering for sale or subscription should know that prospectus approval now falls to the Presidency or Vice-Presidency, except in first admissions without prior prospectus.
- Cross-border operations: If your issuance involves the transfer of prospectus approval authority to another EU Member State, that decision falls exclusively to the Executive Committee.
Who does it affect?
- Companies currently listed on Spanish stock exchanges that carry out primary market operations (capital increases, bond issuance with prospectus, etc.).
- Companies in the process of going public (IPO, OPV, OPS) that have open or pending cases with the CNMV.
- Securities issuers that need to approve or register prospectuses or supplements.
- Financial entities supervised by the CNMV that act as global coordinators or advisors in primary market operations.
- Companies considering a first admission to trading without prior prospectus (affected by the specific exception in the agreement).
- Issuers with cross-border operations requiring transfer of prospectus approval powers to other EU Member States.
Practical example
Imagine a mid-sized technology company that has spent months preparing its entry to the Spanish continuous market through an OPV. It has hired a coordinating bank and has the prospectus almost ready to submit to the CNMV.
Before this agreement, it was not entirely clear which CNMV body would resolve prospectus approval in each specific case. With the new delegation agreement, the company and its legal advisor know with certainty that:
- The approval and registration of the prospectus falls to the Presidency or Vice-Presidency of the CNMV.
- If during the process the CNMV detects that it is necessary to authorize an information omission in the prospectus (for example, for reasons of commercial confidentiality), that decision will be made by the Executive Committee, with the deliberation times that implies.
- If the operation is structured so that prospectus approval is carried out by a regulator from another EU Member State (for example, if the issuer decides to domicile the operation in Luxembourg), it will also be the Executive Committee that authorizes that transfer of powers.
This clarity allows the company's legal and financial team to better plan the timing of each phase of the process and anticipate which decisions may create bottlenecks.
What should companies do now?
- Review the status of your open cases with the CNMV: If you have an admission process, prospectus registration or OPV/OPS underway, identify what phase it is in and which body is now competent to resolve according to this agreement.
- Update your IPO strategy: If you are planning an IPO or capital increase with prospectus, incorporate into your timeline the distinction between Presidency/Vice-Presidency decisions (more agile) and Executive Committee decisions (more deliberative).
- Consult with your legal advisor specialized in securities markets: Especially if your operation includes information omissions in the prospectus, first admissions without prior prospectus or transfer of powers to another EU Member State, as these cases have a specific decision circuit.
- Verify if your operation fits the exception for first admissions without prior prospectus: This type of case is not delegated to Presidency/Vice-Presidency, so the competent body and timelines may differ.
- Maintain fluid communication with the CNMV: The internal reorganization may generate an adaptation period. Make sure your contacts at the CNMV know the new decision circuit applicable to your case.
Frequently asked questions
Which CNMV body now approves prospectuses for an OPV?
As of 6 November 2026, the approval and registration of prospectuses and supplements, as well as the management of public offerings for sale (OPV) and subscription (OPS), falls to the Presidency or Vice-Presidency of the CNMV. The exception is first admissions without prior prospectus, which follow a different circuit.
Who decides at the CNMV if information can be omitted from a prospectus?
Authorization of information omissions in prospectuses is the exclusive responsibility of the Executive Committee of the CNMV, according to the delegation of powers agreement of 27 October 2026. This decision is not delegated to the Presidency or Vice-Presidency.
When does the new CNMV delegation of powers agreement enter into force?
The agreement entered into force on the same day as its publication in the BOE: 6 November 2026. It is applicable immediately to all ongoing and new cases from that date.
Does this agreement affect companies already listed on the stock exchange?
Yes, to the extent that they carry out primary market operations requiring CNMV intervention: capital increases with prospectus, bond issuance, prospectus supplements, etc. The agreement determines which body will resolve each type of case, which has implications for timelines and strategy.
What happens if my operation requires transferring prospectus approval to another EU country?
The transfer of prospectus approval powers to other EU Member States is a decision that falls exclusively to the Executive Committee of the CNMV. It is not delegated to the Presidency or Vice-Presidency, so you should plan for additional deliberation times in your planning.
Official source
Consult complete regulation in official source
Disclaimer: This article is for informational purposes only and does not constitute legal advice. For specific decisions, consult a qualified professional. Source: https://www.boe.es/diario_boe/txt.php?id=BOE-A-2026-23339
